
Walmart join MediLedger medical supply chain blockchain network
pharmafile | June 3, 2019 | News story | Manufacturing and Production | MediLedger, blockchain, medical supply chain, pharma
Walmart has joined the MediLedger network – a network of pharma firms who use a permissioned blockchain to manage the distribution of medical supplies.
The retail giant, who already use IBM’s blockchain network FoodTrust, has now joined the permissioned blockchain network MediLedger, whose members include Genentech, Pfizer and Gilead.
Walmart will use the MediLedger blockchain to improve their business selling healthcare products and medical supplies, a section of their business which accounted for $35 billion in revenue in the last financial year.
Based on Ethereum the MediLedger blockchain keeps an unchangeable record of transactions on a permissioned ledger.
MediLedger itself has set the bar high as it aims to create “an industry-wide network owned by the industry itself, connecting you to all your suppliers and customers.” The project was started in 2017.
Louis Goss
Related Content

Pharma sees climate disruption as growing supply-chain risk
Nine in ten pharmaceutical companies across the UK and G7 countries expect climate-related disruption to …

AI in pharma: From lab development to patient impact
In the decade to 2025, AI use in vaccine development has increased markedly but is …

LGC Group opens $100M Organic Chemistry Synthesis Centre of Excellence
LGC Group, a life sciences company, has opened its new Organic Chemistry Synthesis Centre of …






